Dongbao Enterprise Group Co., Ltd. is a conglomerate industrial group, with more than 20 subsidiaries, actively engaged in the field of pharmaceutical production and is now one of the pioneering manufacturers of recombinant biopharmaceuticals, especially recombinant human insulin.